University of California, San Diego, School of Medicine
La Jolla, California, United States
Medical school in San Diego, California
9500 Gilman Dr, La Jolla, CA 92093
About University of California, San Diego, School of Medicine
The University of California San Diego School of Medicine is the graduate medical school of the University of California, San Diego. It was the third medical school in the University of California system, after those established at UCSF and UCLA, and is the only medical school in the San Diego metropolitan area.
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
University of California, San Diego
4
Hoffmann-La Roche
2
Celgene
1
Columbia University
1
Eisai Inc.
1
George I. Papakostas
1
Mariana Cherner, PhD
1
Massachusetts General Hospital
1
Mitsubishi Tanabe Pharma America Inc.
1
National Center for Research Resources (NCRR)
1
Shanghai MicroPort Medical (Group) Co., Ltd.
1
Clinical Trials at University of California, San Diego, School of Medicine
During the past decade, University of California, San Diego, School of Medicine conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 3 clinical trials were completed, i.e. on
average, 42.9% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Establishment of a Database for Long-Term Monitoring of Patients With Nephropathic Cystinosis
1999-10-01
Completed
400
Phase II Pilot Randomized Study of Sodium Dichloroacetate in Patients With Congenital Lactic Acidemia
1998-09-01
2003-09-01
Completed
75
Study of ONTAK in Patients With B-Cell Chronic Lymphocytic Leukemia (CLL)
2003-03-01
2006-05-01
Completed
41
A Study of 6(S)-5-MTHF Among Serotonin Reuptake Inhibitor(SSRI)-Resistant Outpatients With Major Depressive Disorder (MDD)
2006-11-01
2010-06-01
Completed
150
A Study of Bevacizumab (Avastin) in Combination With Rituximab (MabThera) and CHOP (Cyclophosphamide, Hydroxydaunorubicin [Doxorubicin], Oncovin [Vincristine], Prednisone) Chemotherapy in Patients With Diffuse Large B-cell Lymphoma
2007-07-26
2011-11-30
Terminated
787
Theca Cell Function in Women With Polycystic Ovary Syndrome (PCOS)
2007-09-01
2010-09-01
Completed
25
Study of 6(S)-5-MTHF Among Selective Serotonin Reuptake Inhibitor-Resistant Outpatients With Major Depressive Disorder
2009-07-01
2011-04-01
Completed
75
Theca Cell Function in Adolescents With Polycystic Ovary Syndrome (PCOS)
2011-08-01
2014-09-01
Completed
24
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "University of California, San Diego, School of Medicine" #1 sponsor was "University of California, San Diego" with 4 trials, followed by "Hoffmann-La Roche" with 2 trials
sponsored, "Celgene" with 1 trials sponsored, "Columbia University" with 1 trials sponsored and "Eisai Inc."
with 1 trials sponsored. Other sponsors include 1 different institutions and
companies that sponsored additional 11 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "University of California, San Diego, School of Medicine"
#1 collaborator was "Pamlab, L.L.C." with 2 trials as a collaborator, "Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)" with 1 trials as a collaborator, "Genentech, Inc." with 1 trials as a collaborator, "Michael J. Fox Foundation for Parkinson's Research" with 1 trials as a collaborator and "National Institute on Drug Abuse (NIDA)" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at University of California, San Diego, School of Medicine
According to Clinical.Site data, the most researched conditions in "University of California, San Diego, School of Medicine" are
"Autism Spectrum Disorders" (1 trials), "B-cell Lymphoma" (1 trials), "Carcinoma, Hepatocellular" (1 trials), "Coronary Artery Disease" (1 trials) and "Cystinosis" (1 trials). Many other conditions were trialed in "University of California, San Diego, School of Medicine" in a lesser frequency.
Clinical Trials Intervention Types at University of California, San Diego, School of Medicine
Most popular intervention types in "University of California, San Diego, School of Medicine" are "Drug" (10 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (4 trials), "Bevacizumab" (2 trials), "2nd generation DES (XIENCE family, Promus family, Resolute/Onyx family/Endeavor, and Orsiro stent)" (1 trials), "6(S)-5-MTHF (a Medical Food)" (1 trials) and "6(S)-5-MTHF(Deplin)" (1 trials). Other intervention names were less common.
Clinical Trials Genders at University of California, San Diego, School of Medicine
The vast majority of trials in "University of California, San Diego, School of Medicine" are
12 trials for "All" genders, 2 trials for "Female" genders and 1 trials for "Male" genders.
Clinical Trials Status at University of California, San Diego, School of Medicine
Currently, there are NaN active trials in "University of California, San Diego, School of Medicine".
1 are not yet recruiting,
1 are recruiting,
1 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 10 completed trials in University of California, San Diego, School of Medicine,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in University of California, San Diego, School of Medicine, 1 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 4 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 2 trials, and there were
also 1 trials that are defined as “Not Applicable".